NEW YORK (GenomeWeb) – BioMérieux today reported that its second quarter revenues rose approximately 3 percent year over year. The firm attributed growth to a diversified geographic footprint and comprehensive offerings.

For the three months ended June 30, BioMérieux reported revenues of €582.2 million ($677.1 million), up from €566.4 million in the prior-year period. Organic growth, at constant exchange rates and scope of consolidation, was about 8 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica reports that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.